Viridian Therapeutics
VRDN
VRDN
22 hedge funds and large institutions have $36.6M invested in Viridian Therapeutics in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
15% less funds holding
Funds holding: 26 → 22 (-4)
27% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 15
Holders
22
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$9.05M | |
| 2 | +$7.43M | |
| 3 | +$7.01M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$1.53M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$1.33M |
Top Sellers
| 1 | -$3.01M | |
| 2 | -$284K | |
| 3 | -$255K | |
| 4 |
BlackRock
New York
|
-$94.7K |
| 5 |
VF
Virtu Financial
New York
|
-$87K |